Presymptomatic genetic testing with an APP mutation in Early-onset Alzheimer disease: A descriptive study of sibship dynamics

Kimberly A. Quaid, Jill R. Murrell, Ann M. Hake, Martin R. Farlow, Bernardino Ghetti

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Early-onset Alzheimer disease (AD) accounts for only 5% of all cases of Alzheimer disease. To date, mutations in three different genes, the Amyloid precursor protein (APP), Presenilin 1 (PSI), and Presenilin 2 (PS2), have been identified as causative in early-onset AD, making predictive testing possible. Predictive testing for early-onset Alzheimer disease is a relatively new phenomenon. This paper describes the process of identifying a new mutation in the APP gene associated with early- onset AD, notifying family members, and offering participation in research as well as predictive testing. The goal is to share the complexities of predictive testing in a sibship newly identified as being at risk for an adult-onset, incurable neurodegenerative disease.

Original languageEnglish (US)
Pages (from-to)327-341
Number of pages15
JournalJournal of Genetic Counseling
Volume9
Issue number4
DOIs
StatePublished - Jan 1 2000

Fingerprint

Amyloid beta-Protein Precursor
Genetic Testing
Alzheimer Disease
Mutation
Presenilin-2
Presenilin-1
Neurodegenerative Diseases
Genes
Research

Keywords

  • Alzheimer disease
  • Genetic counseling
  • Predictive testing

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Presymptomatic genetic testing with an APP mutation in Early-onset Alzheimer disease : A descriptive study of sibship dynamics. / Quaid, Kimberly A.; Murrell, Jill R.; Hake, Ann M.; Farlow, Martin R.; Ghetti, Bernardino.

In: Journal of Genetic Counseling, Vol. 9, No. 4, 01.01.2000, p. 327-341.

Research output: Contribution to journalReview article

@article{8028b10629d74c70b92af3733869acb0,
title = "Presymptomatic genetic testing with an APP mutation in Early-onset Alzheimer disease: A descriptive study of sibship dynamics",
abstract = "Early-onset Alzheimer disease (AD) accounts for only 5{\%} of all cases of Alzheimer disease. To date, mutations in three different genes, the Amyloid precursor protein (APP), Presenilin 1 (PSI), and Presenilin 2 (PS2), have been identified as causative in early-onset AD, making predictive testing possible. Predictive testing for early-onset Alzheimer disease is a relatively new phenomenon. This paper describes the process of identifying a new mutation in the APP gene associated with early- onset AD, notifying family members, and offering participation in research as well as predictive testing. The goal is to share the complexities of predictive testing in a sibship newly identified as being at risk for an adult-onset, incurable neurodegenerative disease.",
keywords = "Alzheimer disease, Genetic counseling, Predictive testing",
author = "Quaid, {Kimberly A.} and Murrell, {Jill R.} and Hake, {Ann M.} and Farlow, {Martin R.} and Bernardino Ghetti",
year = "2000",
month = "1",
day = "1",
doi = "10.1023/A:1009406229745",
language = "English (US)",
volume = "9",
pages = "327--341",
journal = "Journal of Genetic Counseling",
issn = "1059-7700",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "4",

}

TY - JOUR

T1 - Presymptomatic genetic testing with an APP mutation in Early-onset Alzheimer disease

T2 - A descriptive study of sibship dynamics

AU - Quaid, Kimberly A.

AU - Murrell, Jill R.

AU - Hake, Ann M.

AU - Farlow, Martin R.

AU - Ghetti, Bernardino

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Early-onset Alzheimer disease (AD) accounts for only 5% of all cases of Alzheimer disease. To date, mutations in three different genes, the Amyloid precursor protein (APP), Presenilin 1 (PSI), and Presenilin 2 (PS2), have been identified as causative in early-onset AD, making predictive testing possible. Predictive testing for early-onset Alzheimer disease is a relatively new phenomenon. This paper describes the process of identifying a new mutation in the APP gene associated with early- onset AD, notifying family members, and offering participation in research as well as predictive testing. The goal is to share the complexities of predictive testing in a sibship newly identified as being at risk for an adult-onset, incurable neurodegenerative disease.

AB - Early-onset Alzheimer disease (AD) accounts for only 5% of all cases of Alzheimer disease. To date, mutations in three different genes, the Amyloid precursor protein (APP), Presenilin 1 (PSI), and Presenilin 2 (PS2), have been identified as causative in early-onset AD, making predictive testing possible. Predictive testing for early-onset Alzheimer disease is a relatively new phenomenon. This paper describes the process of identifying a new mutation in the APP gene associated with early- onset AD, notifying family members, and offering participation in research as well as predictive testing. The goal is to share the complexities of predictive testing in a sibship newly identified as being at risk for an adult-onset, incurable neurodegenerative disease.

KW - Alzheimer disease

KW - Genetic counseling

KW - Predictive testing

UR - http://www.scopus.com/inward/record.url?scp=0033927573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033927573&partnerID=8YFLogxK

U2 - 10.1023/A:1009406229745

DO - 10.1023/A:1009406229745

M3 - Review article

AN - SCOPUS:0033927573

VL - 9

SP - 327

EP - 341

JO - Journal of Genetic Counseling

JF - Journal of Genetic Counseling

SN - 1059-7700

IS - 4

ER -